Skip to main content

Table 1 IRS ratios of Th2/Th1 cytokines in control, untreated and nystatin-treated groups

From: Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis

Group

Th2/Th1 IRS ratio

P

Control

3.14 ± 2.57

 

Untreated

  

4 d

0.90 ± 0.26

0.004a

8 d

0.94 ± 0.70

0.005a

15 d

1.12 ± 0.62

0.009a

Treated

0.97 ± 0.31

0.840b

  1. The Th2/Th1 balance was determined by calculating the IRS ratios of IL-4/IFN-γ in different groups. aP < 0.05 compared with control group. bP > 0.05 compared with untreated 15 d sub-group. Data represent the mean ± standard deviation (n = 6)